Abliva AB (NEVPF)
0.01
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Abliva Total Liabilities (Quarterly): 0.7797M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.7797M |
March 31, 2024 | 0.9668M |
December 31, 2023 | 1.667M |
September 30, 2023 | 1.214M |
June 30, 2023 | 1.256M |
March 31, 2023 | 0.7382M |
December 31, 2022 | 1.875M |
September 30, 2022 | 1.961M |
June 30, 2022 | 1.844M |
March 31, 2022 | 4.501M |
December 31, 2021 | 1.922M |
September 30, 2021 | 2.496M |
June 30, 2021 | 2.176M |
March 31, 2021 | 2.081M |
December 31, 2020 | 1.258M |
September 30, 2020 | 1.009M |
June 30, 2020 | 1.646M |
March 31, 2020 | 0.8611M |
December 31, 2019 | 2.215M |
September 30, 2019 | 1.561M |
June 30, 2019 | 2.110M |
March 31, 2019 | 1.447M |
December 31, 2018 | 2.037M |
September 30, 2018 | 1.484M |
June 30, 2018 | 1.479M |
Date | Value |
---|---|
March 31, 2018 | 1.852M |
December 31, 2017 | 1.744M |
September 30, 2017 | 0.9753M |
June 30, 2017 | 1.203M |
March 31, 2017 | 0.8902M |
December 31, 2016 | 1.369M |
September 30, 2016 | 1.236M |
June 30, 2016 | 1.216M |
March 31, 2016 | 2.448M |
December 31, 2015 | 2.396M |
September 30, 2015 | 3.479M |
June 30, 2015 | 2.587M |
March 31, 2015 | 2.786M |
December 31, 2014 | 3.022M |
September 30, 2014 | 1.340M |
June 30, 2014 | 1.338M |
March 31, 2014 | 2.228M |
December 31, 2013 | 2.267M |
September 30, 2013 | 1.370M |
June 30, 2013 | 1.115M |
March 31, 2013 | 1.223M |
December 31, 2012 | 1.302M |
September 30, 2012 | 0.7243M |
June 30, 2012 | 0.9045M |
March 31, 2012 | 0.4944M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.7382M
Minimum
Mar 2023
4.501M
Maximum
Mar 2022
1.709M
Average
1.667M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
Oncopeptides AB | 14.80M |
BioInvent International AB | 8.369M |
Hansa Biopharma AB | 125.03M |
BioArctic AB | 19.09M |
Camurus AB | 45.05M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 7.132M |
Shareholders Equity (Quarterly) | 6.352M |